Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Therapeutic Drug Monitoring
|
December 18, 2013
Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophrenia
De-Wei Shang, Li-Jun Li, Xi-Pei Wang, et al.
Human Psychopharmacology
|
February 19, 2013
Population pharmacokinetics of blonanserin in Chinese healthy volunteers and the effect of the food intake
Yu-Guan Wen, De-Wei Shang, He-Zhi Xie, et al.
Acta Pharmacologica Sinica
|
July 24, 2012
Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia
Li-jun Li, De-wei Shang, Wen-biao Li, et al.
Frontiers in Pharmacology
|
September 29, 2022
Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients
Xiao-Lin Li, Shan-Qing Huang, Tao Xiao, et al.
Cardiovascular Research
|
August 10, 2019
Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4
Hui Li, Jin-Dong Xu, Xian-Hong Fang, et al.
Frontiers in Pharmacology
|
August 13, 2019
Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy
Zhan-Zhang Wang, Yue-Feng Zhang, Wen-Can Huang, et al.
Molecular Therapy. Nucleic Acids
|
November 17, 2021
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
Ni Zeng, Yu-Qing Huang, Yu-Min Yan, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Therapeutic Drug Monitoring
|
December 18, 2013
Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophrenia
De-Wei Shang, Li-Jun Li, Xi-Pei Wang, et al.
Human Psychopharmacology
|
February 19, 2013
Population pharmacokinetics of blonanserin in Chinese healthy volunteers and the effect of the food intake
Yu-Guan Wen, De-Wei Shang, He-Zhi Xie, et al.
Acta Pharmacologica Sinica
|
July 24, 2012
Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia
Li-jun Li, De-wei Shang, Wen-biao Li, et al.
Frontiers in Pharmacology
|
September 29, 2022
Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients
Xiao-Lin Li, Shan-Qing Huang, Tao Xiao, et al.
Cardiovascular Research
|
August 10, 2019
Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4
Hui Li, Jin-Dong Xu, Xian-Hong Fang, et al.
Frontiers in Pharmacology
|
August 13, 2019
Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy
Zhan-Zhang Wang, Yue-Feng Zhang, Wen-Can Huang, et al.
Molecular Therapy. Nucleic Acids
|
November 17, 2021
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
Ni Zeng, Yu-Qing Huang, Yu-Min Yan, et al.
Page
of 5